• Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

    Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

    Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease

    Learn More
  • <p>Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes</p>

    Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes

    Making Waves: New study published in Nature Communications builds on Ambry’s contributions to MAVE research to deepen understanding of PALB2 and its role in hereditary cancer predisposition.

    Learn More
  • Ambry's Patient for Life™ Study Published in <em>Genetics in Medicine</em>

    Ambry's Patient for Life™ Study Published in Genetics in Medicine

    Peer-reviewed research highlights the power of proactive reanalysis in rare disease diagnosis.

    Learn More

  • Ambry Webinars

    Genetic Clinicians and Rare Sibling Support
    Starting Thursday, February 19th 11:00 AM PST
    Learn More

Dedicated to providing high-quality, accessible genetic testing

Your trusted laboratory for answers and innovation for nearly 25 years.

Hereditary Cancer

Paired DNA/RNA testing with +RNAinsight® analyzes functional RNA data to help detect and classify DNA variants. This approach identifies more positive results, resolves variants of uncertain significance, and reduce evidence gaps in non-White populations.

Learn More

Rare Disease

Exome testing through Ambry Genetics includes proactive reanalysis through our Patient for Life program. This premium service provides updated exome testing findings as new gene-disease discoveries are validated, at no additional cost to the patient.

Learn More

Patient Education & Identification

The Ambry CARE Program® is a unique, end-to-end digital health solution designed to identify patients at increased risk for certain health conditions who may qualify for genetic testing, provide patient education, and facilitate test ordering and result reporting. CARE supports proactive, patient-centric healthcare while enabling practice productivity.

Learn More

What We're Up To
Check out some of the links below

Delivering
Accuracy

Learn More

Bringing
Clarity

Learn More

Advancing
Science

Learn More

Accessible. Affordable. Actionable.

No qualified patient should go without necessary testing due to cost.

five patients

HISTORICALLY, 4 OUT OF 5 PATIENTS PAY

$0

one patient

AVERAGE COST FOR PATIENTS WHO DO PAY

(individual patient responsibility amounts may vary)

LESS THAN

$100

Stay Informed

Sign up for our newsletter and be in the know.
2024 Best CEO
2024 Best Culture
2024 Best Work-Life Balance

Who We Are

With over 20 years of scientific innovations and discoveries, Ambry is an industry leader enabling healthcare professionals to confidently make informed care decisions with their patients by providing them with advanced genetic testing solutions.

At Ambry, people are at the center of our advancements, which starts with our own team. Recognized as an award-winning and outstanding place to work, we maintain a commitment to fostering diverse knowledge and perspectives to drive meaningful collaboration and help us all strive toward better health.

Join Our Team

Patients

Providers

Partners

CARE

Science

Company

Search Results

Start your search...